{
    "clinical_study": {
        "@rank": "122618", 
        "arm_group": {
            "arm_group_label": "Heart Failure"
        }, 
        "biospec_descr": {
            "textblock": "Samples are retained only for this study (troubleshooting purposes)."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic\n      peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis\n      and assessment of the severity of heart failure in point-of-care and laboratory settings.\n      The purpose of the study is to establish the clinical performance of the AQT90 FLEX BNP and\n      NT-proBNP assays for both whole blood and plasma in the intended use population."
        }, 
        "brief_title": "Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is 21 years of age or older\n\n          -  Subject is able to understand information given, and willing and able to voluntarily\n             give their consent to participate in this study\n\n          -  Subject has diagnosis of heart failure\n\n        Exclusion Criteria:\n\n          -  Subject has Acute Coronary Syndrome (ACS)\n\n          -  Subject has been diagnosed and/or treated for malignancy within past 6 months\n\n          -  Subject has had cardiac surgery within the past 4 weeks\n\n          -  Subject claim of pregnancy\n\n          -  Subject's prior participation in this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects 21 years of age or older with heart failure"
            }
        }, 
        "enrollment": {
            "#text": "569", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01808872", 
            "org_study_id": "DC-043652"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Winston-Salem", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27109"
                }, 
                "name": "Wake Forest University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Clinical sensitivity and specificity with 95 % confidence intervals of the AQT90 FLEX BNP and NT-proBNP assays will be determined at the clinical cut-off in heart failure patients divided by age, gender and New York Heart Association (NYHA) functional classification.", 
            "measure": "Determination of the clinical sensitivity and specificity of the AQT90 FLEX BNP and NT-proBNP assays at the clinical cut-off in heart failure patients", 
            "safety_issue": "No", 
            "time_frame": "Single blood draw upon study entry"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01808872"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Radiometer Medical ApS", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Radiometer Medical ApS", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}